Who makes viscosupplementation 3 at once?

viscosupplementation 3 at once is developed by University of Sao Paulo General Hospital.

What development phase is viscosupplementation 3 at once in?

viscosupplementation 3 at once is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

viscosupplementation 3 at once

University of Sao Paulo General Hospital · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	viscosupplementation 3 at once
Sponsor	University of Sao Paulo General Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

"Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
Comparison of Two Application Regimens for Viscosupplementation (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

viscosupplementation 3 at once CI brief — competitive landscape report
viscosupplementation 3 at once updates RSS · CI watch RSS
University of Sao Paulo General Hospital portfolio CI